Building a New Biomedical Ecosystem: Pfizer's Centers for Therapeutic Innovation

    loading  Checking for direct PDF access through Ovid

Abstract

It is becoming increasingly clear that to significantly enhance research and development productivity and innovation, new external partnerships are essential. Although partnership between academia and industry is not a novel concept, the manner in which such collaborations are designed and implemented has evolved. In 2010, Pfizer took decisive steps to form the Centers for Therapeutic Innovation: a partnership model with academia based on true collaboration, reflected by trans-parency, shared decision making, and aligned incentives for sustainable innovation.

Related Topics

    loading  Loading Related Articles